REGN
Regeneron Pharmaceuticals Inc. Healthcare - Biotechnology Investor Relations →
YES
0.6% BELOW
↓ Approaching
Was 4.4% last week
Buy Threshold
$763.76
14-Week RSI
74
Advertisement
Historical Touches
REGN has crossed below its 200-week MA 25 times with an average 1-year return of +19.7% after recovery.
| Date | Weeks Below | Max Depth | 1-Year Return |
|---|---|---|---|
| Sep 2003 | 120 | -70.2% | +47.4% |
| May 2006 | 2 | -2.6% | +74.2% |
| Jul 2006 | 2 | -8.7% | +11.4% |
| Jun 2008 | 5 | -5.0% | +8.0% |
| Nov 2008 | 3 | -13.6% | +12.7% |
| Jan 2009 | 1 | -6.4% | +52.5% |
| Feb 2009 | 16 | -25.4% | +43.4% |
| Jul 2009 | 3 | -7.5% | +15.7% |
| Oct 2009 | 3 | -14.4% | +36.2% |
| Nov 2009 | 1 | -1.6% | +55.2% |
| Jun 2016 | 1 | -1.6% | +37.0% |
| Oct 2016 | 3 | -6.9% | -3.6% |
| Dec 2016 | 10 | -8.6% | -12.0% |
| Mar 2017 | 2 | -3.0% | -17.5% |
| Apr 2017 | 3 | -4.4% | -19.4% |
| Oct 2017 | 64 | -30.7% | -7.9% |
| Feb 2019 | 1 | -2.1% | -5.8% |
| Mar 2019 | 1 | -2.9% | +12.3% |
| Mar 2019 | 38 | -28.8% | +27.5% |
| Dec 2019 | 3 | -1.7% | +30.8% |
| Jan 2020 | 2 | -9.9% | +30.7% |
| Nov 2024 | 1 | -1.4% | +4.6% |
| Dec 2024 | 50 | -36.0% | N/A |
| Dec 2025 | 2 | -5.4% | N/A |
| Jan 2026 | 1+ | -0.6% | Ongoing |
| Average | 13.5 | — | +19.7% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-01-13